Ultradeep sequencing reveals HIV-1 diversity and resistance compartmentalization during HIV-encephalopathy

AIDS. 2020 Sep 1;34(11):1609-1614. doi: 10.1097/QAD.0000000000002616.

Abstract

Objectives: To examine viral diversity and resistance mutations in different brain areas in cases of HIV-encephalopathy.

Design: Twelve postmortem brain areas from three cases of possible or certain HIV-encephalopathy were analyzed.

Methods: After amplification of the reverse transcriptase and the V3 loop region of the gp120 protein, ultradeep sequencing was performed with Illumina technology. Phylogenetic analysis was performed with Fastree v2.1 using the generalized time-reversible (GTR) model. Identification of resistant viral variants was performed on Geneious software, according to HIV-1 genotypic drug resistance interpretation's algorithms, 2018 administered by the French Agency for Research on AIDS and Viral Hepatitis.

Results: Phylogenetic analysis revealed significant inter-regional and intra-regional diversity reflecting persistent HIV-1 viral replication in the different brain areas. Although some cerebral regions shared HIV-variants, most of them harbored a specific HIV-subpopulation reflecting HIV compartmentalization in the central nervous system. Furthermore, proportion and distribution of resistance mutations to nucleoside and non-nucleoside reverse transcriptase inhibitors differed among different brain areas of the same case suggesting that penetration of antiretroviral treatment may differ from one compartment to another.

Conclusion: This study, performed with a powerful sequencing technique, confirmed HIV compartmentalization in the central nervous system already shown by classical sequencing, suggesting that there are several reservoirs within the brain.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AIDS Dementia Complex / genetics*
  • Amplified Fragment Length Polymorphism Analysis
  • Anti-HIV Agents / therapeutic use*
  • Anti-Retroviral Agents / therapeutic use*
  • Drug Resistance, Viral / genetics*
  • Genotype
  • HIV Envelope Protein gp120
  • HIV Infections / drug therapy*
  • HIV-1 / drug effects*
  • HIV-1 / genetics
  • High-Throughput Nucleotide Sequencing / methods*
  • Humans
  • Mutation / drug effects
  • Phylogeny
  • Reverse Transcriptase Polymerase Chain Reaction

Substances

  • Anti-HIV Agents
  • Anti-Retroviral Agents
  • HIV Envelope Protein gp120
  • gp120 protein, Human immunodeficiency virus 1